Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3
Open Access
- 1 March 2024
- journal article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 48 (2), 171-180
- https://doi.org/10.1016/j.jgr.2021.05.008
Abstract
No abstract availableFunding Information
- Hospital Research Foundation
This publication has 42 references indexed in Scilit:
- Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination TreatmentsCancers, 2021
- Anti-Angiogenic Properties of Ginsenoside Rg3Molecules, 2020
- Ginsenoside Rg3 (Shenyi Capsule) Combined with Chemotherapy for Digestive System Cancer in China: A Meta-Analysis and Systematic ReviewEvidence-Based Complementary and Alternative Medicine, 2019
- Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell ModelsPharmaceuticals, 2019
- Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast CancerMedicines, 2019
- Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutationOncotarget, 2016
- Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular CarcinomaRadiology, 2016
- Stereoselective pharmacokinetic and metabolism studies of 20(S)- and 20(R)-ginsenoside Rg3 epimers in rat plasma by liquid chromatography-electrospray ionization mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2016
- Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancerChinese Journal of Integrated Medicine, 2008
- High performance liquid chromatographic–mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studiesJournal of Chromatography B, 2005